News

Press Release Apr 25 2025 FORE Biotherapeutics Presents New Plixorafenib Results at AACR 2025 Demonstrating Pharmacodynamic Effect in Clinical Tumor Biopsies and Decreased V600E Mutant Allele Frequency in ctDNA of 85% of Patients Read more

Press Release Mar 31 2025 FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer Research Annual Meeting 2025 Read more

Press Release Feb 13 2025 FORE Biotherapeutics to Participate in the Raymond James Private Biotech Symposium Read more

Press Release Jan 09 2025 FORE Biotherapeutics Highlights Recent Pipeline Achievements for its Targeted-Oncology Program and Provides Strategic Objectives for 2025 Read more

Press Release Dec 19 2024 FORE Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference Read more

Press Release Dec 05 2024 FORE Biotherapeutics to Participate in the Wells Fargo Virtual Private Biotech Symposium Read more

Press Release Nov 07 2024 FORE Biotherapeutics to Participate in Upcoming Investor Conferences Read more

Press Release Oct 08 2024 FORE Biotherapeutics Presents at RBC Capital Markets 2024 Virtual Biotechnology Private Company Conference Read more

Press Release Sep 26 2024 FORE Biotherapeutics Presents at UBS 2024 Biotechnology Private Company Virtual Symposium Read more